Chinese Hepatolgy ›› 2026, Vol. 31 ›› Issue (9): 1253-1257.

• Liver Fibrosis and Cirrhosis • Previous Articles     Next Articles

A construction of a nomogram model to predict the risk of the first episode of occult hepatic encephalopathy in cirrhotic patients

Gu Zhengtai1, Liu Weiwei1, Gu Lingyun2, Ma Chenbin1   

  1. 1. Department of Infectious Diseases, Rugao Hospital Affiliated to Nantong University, Nantong 226500, China;
    2. Tuberculosis Clinic, Rugao Hospital Affiliated to Nantong University,Nantong 226500, China
  • Received:2025-09-07 Online:2026-09-30 Published:2026-11-16
  • Contact: Ma Chenbin, Email: mcb321@163.com

Abstract: Objective To construct a nomogram model in order to predict the risk of the first episode of occult hepatic encephalopathy (CHE) in cirrhotic patients. Methods A total of 208 patients with cirrhosis who were admitted in Rugao Hospital between May 2021 and May 2023 were selected. The independent risk factors for first episode of CHE in cirrhotic patients were analyzed using multifactorial logistic regression. A predictive nomogram were further established based on these risk factors, and the internal data set was used for the calibration curve, decision curve and clinical impact curve analyses. Results Among the 208 patients, the prevalence rate of first-episode of covert hepatic encephalopathy (CHE) was 41.3%. Compared to non-CHE patients, CHE patients showed significantly higher proportions of diabetes (58.1% vs. 35.0%), ascites (37.0% vs.22.0%), and Child-Pugh grade B (39.5% vs. 22.1%), with statistically significant differences (P<0.05). The average age,handgrip strength, model for end-stage liver disease score, albumin-bilirubin score, and prothrombin time were (68.5±5.9) years, (21.89±3.36) kg, (9.57±5.38), (-2.07±0.48), (16.95±1.98) s for CHE patients, and (64.2±5.3) years, (23.29±3.99) kg, 7.12±4.36, -2.40±0.52, and (15.77±1.37) s for non-CHE patients, respectively. The blood urea nitrogen, platelet count, and albumin level were (7.11±1.93) mmol/L, (100.56±40.54) × 109/L, and (30.54±3.76) g/L in CHE patients, respectively, which were significantly higher than those of (6.40±2.48) mmol/L, (128.54±46.53) × 109/L, and (33.32±3.72) g/L in non-CHE patients (all P<0.05). Multivariate logistic regression analysis identified age, diabetes, handgrip strength, albumin, and blood urea nitrogen as independent risk factors for first-episode of CHE in cirrhotic patients (OR=1.628, 2.072, 3.326, 0.711, and 1.426, respectively; P<0.05). The calibration curve of the nomogram demonstrated excellent predictive accuracy with a C-index of 0.906. Decision curve analysis revealed that the nomogram provided clinically meaningful standardized net benefits within a risk threshold range of 0.153~0.876. The clinical impact curve analysis indicated that when the predicted probability threshold exceeded 40%, the nomogram's predictive accuracy closely approximated the actual observed outcomes. Conclusion In this study, a nomogram model constructed based on age, diabetes, handgrip strength, albumin, and blood urea nitrogen in cirrhotic patients was effective in quantifying the risk of a first episode of CHE in cirrhotic patients, which provided a method for healthcare professionals to assess the patient's condition and prognosis.

Key words: Liver cirrhosis, Cryptic, Hepatic encephalopathy, Nomogram